abstract |
The present invention generally relates to antibodies that bind CD71, activatable antibodies that specifically bind to CD71, and methods of making these anti-CD71 antibodies and anti-CD71 activatable antibodies and using these anti-CD71 antibodies and anti-CD71 antibodies in various therapeutic, diagnostic, and prophylactic indications Methods of CD71-activatable antibodies. |